| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/31/2006 | CN1780854A Insulin analogs having protracted time action |
| 05/31/2006 | CN1780853A Secreted protein family |
| 05/31/2006 | CN1780852A Group 1 mite polypeptide variants |
| 05/31/2006 | CN1780640A Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
| 05/31/2006 | CN1780633A Pharmaceutical compositions for treating painful neuropathy and methods of treating same |
| 05/31/2006 | CN1780553A Generation of plants with altered oil content |
| 05/31/2006 | CN1778927A Coding nucleotide sequence of cupular virus capsid protein with codon optimization and use thereof |
| 05/31/2006 | CN1778920A Antibiotic peptide gene and its yeast expression carrier |
| 05/31/2006 | CN1778919A Human MDR1 gene expression regulator screening system and method for screening gene expression regulator |
| 05/31/2006 | CN1778821A Granular leukocyte colony-stimulating factors coupling agent with chemical modification and production thereof |
| 05/31/2006 | CN1778820A Recombinant VPAC2 receptor specific agonist RMBAY, its expression and use |
| 05/31/2006 | CN1778819A Recombinant VPAC2 receptor specific agonist RMROM, its expression and use |
| 05/31/2006 | CN1778818A Pig production and immune character related protein, its coding gene and use |
| 05/31/2006 | CN1778817A Protein and sugar binding protein with anti-HIV activity |
| 05/31/2006 | CN1778816A Human cell surface membrane molecule and use thereof |
| 05/31/2006 | CN1778815A Indica rice classified control gene PHR1 and use thereof |
| 05/31/2006 | CN1778814A Binding protein of tall fescue drought reacting element, its coding gene and use thereof |
| 05/31/2006 | CN1778813A Plant epidermic hair control gene |
| 05/31/2006 | CN1778812A Nolvac viral coat protein with recombinant rod virus expression and its preparation |
| 05/31/2006 | CN1778280A Mouse asthmatic model semiotic monitor of acoustical sensor |
| 05/31/2006 | CN1257976C Improved vaccines |
| 05/31/2006 | CN1257975C Plasmid of recombinant immunotoxin Rantes-DT390 aimed at activating Th1 cell, and its preparing method and use |
| 05/31/2006 | CN1257973C Broad spectrum infectious chicken blader disease virus vaccine |
| 05/31/2006 | CN1257917C Process for preparing collagen active polypeptide from avian animal tissue |
| 05/31/2006 | CN1257916C Parathyroid hormone analog and its preparing process by recombination |
| 05/30/2006 | US7053283 Hybrid maize 36W66 |
| 05/30/2006 | US7053282 transgenic seed of transgenic cereal plant comprising an elevated level of lysine or sulfur-containing amino acid compared to a corresponding non-transgenic cereal plant seed; for increasing the nutritional value of feed |
| 05/30/2006 | US7053270 Transgenic cotton plant for use in the generation of cotton fibers with amplified fiber characteristics |
| 05/30/2006 | US7053269 Construction of a recombinant DNA construct encoding the phospholipid, in sense or antisense orientation, wherein expression of the recombinant DNA construct results in production of altered levels of the phospholipid |
| 05/30/2006 | US7053266 Chimeric cry1E δendotoxin and methods of controlling insects |
| 05/30/2006 | US7053265 Nucleotide sequences for use as tools in the expression of heterologous gene in plants |
| 05/30/2006 | US7053262 Activation; transgenic rodent; genetic engineering |
| 05/30/2006 | US7053205 for initiation of transcription; for production of transgenic plants |
| 05/30/2006 | US7053204 Polypeptides, nucleic acids; gene codes; antibiotic, immunosuppressants |
| 05/30/2006 | US7053203 Gene controlling ethylene synthesis |
| 05/30/2006 | US7053200 Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation |
| 05/30/2006 | US7053197 Ketogulonigenium endogenous plasmids |
| 05/30/2006 | US7053196 Ketogulonigenium endogenous plasmids |
| 05/30/2006 | US7053194 Compositions and methods for p53-mediated repression of gene expression |
| 05/30/2006 | US7053193 Up-regulated breast cancer transcription factor amino acid sequence |
| 05/30/2006 | US7053190 Antibody for use in the treatment and diagnosis of immunological and lysomal defect |
| 05/30/2006 | US7053189 Human dopamine receptor and its uses |
| 05/30/2006 | US7053186 Protein for use in diagnosis and treatment of cancer |
| 05/30/2006 | US7053185 contacting alpha-lactalbumin (in molten globule-like state) with fatty acids and lipids found in a milk fraction containing casein obtained from humans; antibacterial agents; anticancer agents |
| 05/30/2006 | US7053184 Expression vector coding polypeptide with thrombin proteolytic sequences; for use in evaluating ligand binding and signal transduction |
| 05/30/2006 | US7053183 Human cyclic nucleotide-gated cation channel polypeptide |
| 05/30/2006 | US7053182 for transgenic plants |
| 05/30/2006 | US7053181 Canine and feline B7-2 proteins, compositions and uses thereof |
| 05/30/2006 | US7053180 Isolated islet beta-cell two-pore domain potassium channel |
| 05/30/2006 | US7053179 Inhibits hiv infection of cells |
| 05/30/2006 | US7053178 biotinylation; for inhibiting activity of anti-beta-2-glycoprotein 1 monoclonal antibodies in vitro |
| 05/30/2006 | US7053175 Delta -Z-TrpGlyCys- Theta -CysTyrThrSer- Omega, ( Delta represents a biotinyl radical, a biocytinyl radical, a hydrogen atom, an acetyl (CH3CO ) radical, an aliphatic chain which may contain one or two thiol, aldehyde or amine functional groups, and Z= a peptide sequence) |
| 05/30/2006 | US7053062 Compositions and methods for inducing gene expression |
| 05/30/2006 | US7053058 For inhibiting growth of prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian or other cancers of epithelial secretion, or benign prostate hyperplasia |
| 05/30/2006 | US7053054 Purified LH |
| 05/30/2006 | US7053053 for diagnostic/therapeutic/prophylactics for neurodegenerative diseases, brain dysfunctions, cancers, gastrointestinal/circulatory/endocrine diseases and cell death; genetic engineering |
| 05/30/2006 | US7053052 for enhancing immunogenicity activity of tumor cells; tumor/drug targets |
| 05/30/2006 | US7053046 Peptide activators of VEGF |
| 05/30/2006 | US7053045 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 05/30/2006 | US7053044 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant |
| 05/30/2006 | US7053042 Activation of peptide prodrugs by hK2 |
| 05/30/2006 | US7052915 Selective labeling and isolation of phosphopeptides and applications to proteome analysis |
| 05/30/2006 | US7052908 Androgen receptor coactivators |
| 05/30/2006 | US7052906 Synthetic transmembrane components |
| 05/30/2006 | US7052900 Saccharomyces cerevisiae yeast strain with functional expression of a Glut transporter |
| 05/30/2006 | US7052899 Toxoplasma gondii proteins, nucleic acid molecules, and uses thereof |
| 05/30/2006 | US7052896 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 05/30/2006 | US7052895 nucleotide sequences that code amino acid sequences having hydrolase enzyme activity, used for medical diagnosis, for prophylaxis of diseases and drug screening; bioassay |
| 05/30/2006 | US7052889 Mammalian SUV39H2 proteins and isolated DNA molecules encoding them |
| 05/30/2006 | US7052883 Process for the production of L-amino acids using strains of the family Enterobacteriaceae that contain an attenuated fruR gene |
| 05/30/2006 | US7052881 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 05/30/2006 | US7052876 generating DNA libraries having variable lengths and sequences comprising ligation of DNA molecules having receptivity to one another and are equivalent to the cleavage products of different but compatible restriction enzymes and cutting to desired orientation |
| 05/30/2006 | US7052874 Killing microorganism; measurement, calibration antibiotic resistance |
| 05/30/2006 | US7052871 modulating gene expresssion of corn cells with expression cassette comprising genetic enhancers to the presence of plant growth regulators that are linked to polynucleotides that code polypeptides; genetic engineering; hybrids |
| 05/30/2006 | US7052870 nucleotide sequences and complements that code mammalian targets of ripamycin (mTOR) and rapamycin insensitive companion of mammalian targets of ripamycin (rictor), used as screening targets for the identification and drugs which modulate the activity of enzymes |
| 05/30/2006 | US7052867 Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same |
| 05/30/2006 | US7052862 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 05/30/2006 | US7052860 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 05/30/2006 | US7052858 Novel Cryptosporidium parvum protein disulfide isomerase polypeptide, and nucleic acids that encode this polypeptide. The invention also provides methods, reagents, and kits that are useful for diagnosing infection by Cryptosporidium |
| 05/30/2006 | US7052857 Compounds that activate the olfactory CNG channel will enhance smell and can be used to make foods more palatable for individuals with attenuated olfactory function |
| 05/30/2006 | US7052856 Contacting a cell containing a NELL-1 gene with a test agent; and detecting a change in the expression level of Nell-1 gene as compared to the expression of the NELL-1 gene in a cell that is not contacted with test agent |
| 05/30/2006 | US7052853 Depression gene |
| 05/30/2006 | US7052850 Isolated human EDG-4 receptor |
| 05/30/2006 | US7052849 Antibody for use in the diagnosis of diabetic disorders |
| 05/30/2006 | US7052830 diagnosing infection by way of binding an antibody or antigen reading frame then translating open; vaccines |
| 05/30/2006 | US7052720 Spheroid preparation |
| 05/30/2006 | US7052705 Useful to control pathological angiogenesis, such as occurs in cancer and other diseases |
| 05/30/2006 | US7052704 Comprises fatty acid-conjugated products with disulfide linkage to proteins/peptides for delivery to cells; increases absorption and prolongs blood and tissue retention |
| 05/30/2006 | US7052703 T-cell receptorγ alternate reading frame protein, (TARP) and uses thereof |
| 05/30/2006 | US7052702 comprises a light-chain or a heavy-chain fragment of a Pseudonomas neurotoxin with a proteolytically active enzyme domain; N-acetylgalactosamine-binding lectins; to inhibit the release of neurotransmitters from neurons thereby reducing and/or preventing transmission of afferent pain signals |
| 05/30/2006 | US7052699 Immunogenic composition |
| 05/30/2006 | US7052698 Surface proteins of Leptospira |
| 05/30/2006 | US7052697 immunogenic component stimulates antibody production in avian and/or pocine animals; gastrointestinal disorders |
| 05/30/2006 | US7052696 Antigenic epitopes and mosaic polypeptides of hepatitis C virus proteins |
| 05/30/2006 | US7052695 Angiopoietins and methods of treating hypertension |
| 05/30/2006 | US7052694 Immunoglobulin which specifically binds cell surface protein of nervous system tissue for preventing infections and treating tumors; anticarcinogenic agents; bactericides |
| 05/30/2006 | US7052691 Vascular Endothelial Growth Factors (VEGF) by injection; for decreased serum glucose concentrations, improved glucose tolerance, increased insulin sensitivity, and reduced hyperinsulinemia |
| 05/30/2006 | US7052689 Preventing viral replication in cells; obtain cells, incubate with viricide, monitor cells for reduced viral activity |
| 05/30/2006 | US7052687 Human recombinant beta-interferon with improved solubility |
| 05/30/2006 | US7052686 Pegylated interleukin-10 |